Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Goodbody Health Ltd GDBYF

Healthcare Drug Manufacturers - Specialty & Generic
Goodbody Health Ltd is a wellness company operating in both COVID testing in the United Kingdom and as a vertically integrated cannabinoid CBD company that operates in the United Kingdom and the European Union. It has interests in COVID testing clinics, CBD extraction, wholesale bulk isolate, and distillate sales, retail CBD and white label sales, cannabinoid laboratory testing, and medicinal cannabis research programs.


GREY:GDBYF - Post by User

Goodbody Health Ltd > Merger
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2078)
•••
Comment by lscfaon Mar 02, 2020 9:24am
52 Views
Post# 30755282

RE:RE:RE:RE:RE:RE:Merger

RE:RE:RE:RE:RE:RE:Merger

Makes more sense to use STIL to supply Europe and Columbia operations to supply Latin America and the USA.  Pharmacielo has already shipped to the USA.  


https://investors.pharmacielo.com/2019-09-25-PharmaCielo-Enters-the-U-S-with-3-Million-Q4-Sales-Agreement-and-Completes-Introductory-Shipments-to-Multi-state-Distributor-General-Extract-LLC


drmaddogs2 wrote:
All speculation but in this scenario.... where a cultivar/million pds @ 14%+ in Columbia was Supercritical recovered to lessor volume(Columbian operation) and Stil had a import permit then to go from that stage of distillation upwards- Honey Oil- Isolate- Nano.. I'm pretty sure Horizon would need build out. Perhaps this is what Mota is thinking? With Stil's assets, Sovereignport handling shipping and Poland already permitting Mj imports for medical Mj it isn't out of the realm of possibility for getting Horizon and its production capacity all done in this year.

 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities